Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Publikationen
Suchbegriffe: NEUROENDOCRINE TUMORS - DRUG THERAPY , . Treffer: 10
2018
Alvarez, MJ; Subramaniam, PS; Tang, LH; Grunn, A; Aburi, M; Rieckhof, G; Komissarova, EV; Hagan, EA; Bodei, L; Clemons, PA; Dela Cruz, FS; Dhall, D; Diolaiti, D; Fraker, DA; Ghavami, A; Kaemmerer, D; Karan, C; Kidd, M; Kim, KM; Kim, HC; Kunju, LP; Langel, U; Li, Z; Lee, J; Li, H; LiVolsi, V; Pfragner, R; Schwach, G; Rainey, AR; Realubit, RB; Remotti, H; Regberg, J; Roses, R; Rustgi, A; Sepulveda, AR; Serra, S; Shi, CJ; Yuan, XP; Barberis, M; Bergamaschi, R; Chinnaiyan, AM; Detre, T; Ezzat, S; Frilling, A; Hommann, M; Jaeger, D; Kim, MK; Knudsen, BS; Kung, AL; Leahy, E; Metz, DC; Milsom, JW; Park, YS; Reidy-Lagunes, D; Schreiber, S; Washington, K; Wiedenmann, B; Modlin, I; Califano, A
A precision oncology approach to the pharmacological targeting of mechanistic dependencies in neuroendocrine tumors.
Nat Genet. 2018; 50(7):979-989
Doi: 10.1038/s41588-018-0138-4
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2017
Pfanzagl, B; Mechtcheriakova, D; Meshcheryakova, A; Aberle, SW; Pfragner, R; Jensen-Jarolim, E
Activation of the ileal neuroendocrine tumor cell line P-STS by acetylcholine is amplified by histamine: role of H3R and H4R.
Sci Rep. 2017; 7(1):1313-1313
Doi: 10.1038/s41598-017-01453-5
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2016
Arvidsson, Y; Johanson, V; Pfragner, R; Wängberg, B; Nilsson, O
Cytotoxic Effects of Valproic Acid on Neuroendocrine Tumour Cells.
Neuroendocrinology. 2016; 103(5):578-591
Doi: 10.1159/000441849
Web of Science
PubMed
FullText
FullText_MUG
2013
Haas, HS; Pfragner, R; Tabrizi-Wizsy, NG; Rohrer, K; Lueftenegger, I; Horwath, C; Allard, N; Rinner, B; Sadjak, A
The influence of glutamate receptors on proliferation and metabolic cell activity of neuroendocrine tumors.
Anticancer Res. 2013; 33(4): 1267-1272.
Web of Science
PubMed
Hofer, D; Schwach, G; Ghaffari Tabrizi-Wizsy, N; Sadjak, A; Sturm, S; Stuppner, H; Pfragner, R
Christia vespertilionis plant extracts as novel antiproliferative agent against human neuroendocrine tumor cells.
Oncol Rep. 2013; 29(6):2219-2226
Doi: 10.3892/or.2013.2367
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2012
Kalhan, A; Gharibi, B; Vazquez, M; Jasani, B; Neal, J; Kidd, M; Modlin, IM; Pfragner, R; Rees, DA; Ham, J
Adenosine A2A and A2B receptor expression in neuroendocrine tumours: potential targets for therapy.
Purinergic Signal. 2012; 8(2):265-274
Doi: 10.1007/s11302-011-9280-5
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2011
Svejda, B; Kidd, M; Kazberouk, A; Lawrence, B; Pfragner, R; Modlin, IM
Limitations in small intestinal neuroendocrine tumor therapy by mTor kinase inhibition reflect growth factor-mediated PI3K feedback loop activation via ERK1/2 and AKT.
CANCER-AM CANCER SOC. 2011; 117(18): 4141-4154.
Doi: 10.1002/cncr.26011
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2010
Haeubl, M; Schuerz, S; Svejda, B; Reith, LM; Gruber, B; Pfragner, R; Schoefberger, W
Asymmetrically substituted cationic indole- and fluorene porphyrins inhibit tumor proliferation in small intestinal neuroendocrine tumors and medullary thyroid carcinomas.
Eur J Med Chem. 2010; 45(2): 760-773.
Doi: 10.1016/j.ejmech.2009.11.025
Web of Science
PubMed
FullText
FullText_MUG
Svejda, B; Aguiriano-Moser, V; Sturm, S; Höger, H; Ingolic, E; Siegl, V; Stuppner, H; Pfragner, R
Anticancer activity of novel plant extracts from Trailliaedoxa gracilis (W. W. Smith and Forrest) in human carcinoid KRJ-I Cells.
Anticancer Res. 2010; 30(1):55-64
Web of Science
PubMed
2008
Kidd, M; Drozdov, I; Joseph, R; Pfragner, R; Culler, M; Modlin, I
Differential cytotoxicity of novel somatostatin and dopamine chimeric compounds on bronchopulmonary and small intestinal neuroendocrine tumor cell lines.
Cancer. 2008; 113(4): 690-700.
Doi: 10.1002/cncr.23700
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG